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Congenital Intrahepatic Portosystemic
Venous Shunt and Liver Mass in a Child
Patient: Successful Endovascular
Treatment with an Amplatzer Vascular
Plug (AVP)
A congenital intrahepatic portosystemic shunt is a rare anomaly; but, the num-
ber of diagnosed cases has increased with advanced imaging tools. Symptomatic
portosystemic shunts, especially those that include hyperammonemia, should be
treated; and various endovascular treatment methods other than surgery have
been reported. Hepatic masses with either an intra- or extrahepatic shunt also
have been reported, and the mass is another reason for treatment. Authors report
a case of a congenital intrahepatic portosystemic shunt with a hepatic mass that
was successfully treated using a percutaneous endovascular approach with vas-
cular plugs. By the time the first short-term follow-up was conducted, the hepatic
mass had disappeared.
congenital intrahepatic portosystemic venous shunt (IPSVS) is a rare
anomaly that manifests with symptoms of hepatic encephalopathy or
hypoglycemia (1). Sometimes, these findings are found incidentally (2);
however, when a portosystemic shunt carries an increased risk of hepatic
encephalopathy or is associated with the development of liver tumors, it requires
treatment (3). Treatment modalities vary and include dietary control, surgery and,
recently, endovascular methods (4-7).
In this report, we present an 8-year-old male pediatric patient who had congenital
IPSVS with a hepatic mass and hyperammonemia. He underwent successful treatment
by percutaneous embolization with vascular plugs, and his hepatic mass also
disappeared. 
CASE REPORT
An 8-year-old boy was referred to our hospital due to abdominal pain. He had a
history of neonatal hepatitis and had been diagnosed with congenital IPSVS six years
before. The shunt was not corrected at that time because his parents were concerned
about the possible complications associated with the therapeutic procedure. Currently,
the boy is under medication for attention-deficit hyperactivity disorder. Laboratory
values have shown a prolonged coagulation profile and slightly elevated ammonia
level: prothrombin time, 20.1 sec; INR (international normalized ratio), 2.02; and
ammonia, 55 Umol/L. Conservative management relieved his abdominal pain.
Abdominal ultrasonogram (US) demonstrated anechoic tubular structures connecting
the left portal vein and the dilated left hepatic vein with a small-sized right portal vein.
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AColor Doppler imaging revealed high-velocity, continuous
waveform through the shunt; which are consistent with
IPSVS. Enhanced computed tomography (CT) confirmed
the sonographic findings. Three, variably-sized tubular
vessels connected the left portal vein and the left hepatic
vein, forming a loop-like appearance. In the liver’s right
lobe, we found a 3.5-cm sized mass, which showed hetero-
geneous nodular enhancement on the arterial phase and a
mostly prolonged enhancement on five-minute delayed
images (Fig. 1A). This mass was not found on the imaging
study taken six years before. We thought it was possibly a
benign tumor such as hemangioendothelioma or focal
nodular hyperplasia (FNH), but we could not exclude a
malignancy. 
The patient’s parents didn’t want their child to undergo
an invasive procedure for the IPSVS; thus, the pediatrician
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Fig. 1. Congenital intrahepatic portosystemic venous shunt and liver mass in child patient.
A. Contrast-enhanced multidetector CT scan performed before embolization revealed 3.5 cm mass with heterogeneous enhancement in
liver’s right lobe.
B. Right anterior oblique digital subtraction direct portogram demonstrated direct connection between dilated left portal vein and left
hepatic vein by three variable shunt channels. Right portal vein was very small, compared to left portal vein.
C. Right anterior oblique digital subtraction direct portogram immediately after embolization showed successful occlusion of intrahepatic
portosystemic shunt and improvement of flow through right portal vein.
D. Oblique coronal reformatted CT scan image one month after procedure showed markedly increased size of right portal veins,
compared to B.
CDdecided to conduct a close follow-up. At six-month follow-
up, the boy’s blood ammonia level had risen to 94 Umol/L,
which is four times the normal range. A follow-up CT scan
showed no significant change in the IPSVS and hepatic
mass. Shunt ratio was calculated through the Doppler US
(8), by dividing the blood flow volume at the shunt orifice
(814 cc/min) by the total portal blood flow volume (882
cc/min). The shunt ratio was 92%, so we thought that the
patient’s condition could progress to hepatic encephalopa-
thy. Therefore, we decided to close the shunt via endovas-
cular treatment. 
Under general anesthesia, an US-guided transhepatic
right portal vein puncture was performed using a 22G
needle, followed by the insertion of a 7 Fr, 24 cm sheath
(Super Arrow-Flex: Arrow, PA). A direct portogram
showed that the dilated left portal vein was connected
directly with the dilated left hepatic vein by three variable
tubular shunt channels (Fig. 1B). The right portal vein was
very small compared to the left; hence, we chose to treat
the boy with an Amplatzer vascular plug (AVP; AGA
Medical, MN) because of the shunt’s large size. A 20-mm
AVP was deployed into the distal part of the largest shunt
channel and two 12 mm AVPs were placed on the other
smaller shunt channels. A post-embolization portography
identified the absence of blood flow through the shunts
and increased flow in the right portal vein (Fig. 1C). As we
withdrew the sheath, we injected thick gelfoam slurry
through the sheath’s tract to avoid intra-abdominal
bleeding. However, the patient’s blood pressure suddenly
dropped to 60/30 mmHg during the compression of the
puncture site. US showed bleeding from the sheath’s tract.
We performed a vigorous resuscitation and US-guided
compression of the bleeding focus. He experienced
transient hypovolemic shock, but improved within 24
hours and recovered fully without further complication. 
Six days after the procedure, the patient’s serum
ammonia level had decreased to within the normal range
(25 Umol/L), and was discharged nine days post-emboliza-
tion. An abdominal US performed two weeks later,
showed occluded shunts and a slight decrease in the size of
the hepatic mass. The right portal vein’s blood flow had
increased markedly with decreased main portal flow and
minimally increased spleen size. A follow-up CT scan a
month later showed complete embolization of the IPSVS
along with improved portal flow to the right lobe (Fig. 1D),
and nearly complete disappearance of the hepatic mass.
Further, the patient was doing well at four months after
embolization.
DISCUSSION
A congenital IPSVS is rare anomaly that results from
abnormal embryologic development of the vitelline vein,
or a variety of persistent patent ductus venosus (3, 6). 
In patients with congenital IPSVS, some close sponta-
neously or can be asymptomatic for many years (3). Early
diagnosis is important, even though patients can be
asymptomatic, because the shunt’s persistent patency
causes hyperammonemia and increases the risk of hepatic
encephalopathy (1, 9, 10). 
Intrahepatic portosystemic venous shunt must be treated
in patients with hepatic encephalopathy. In asymptomatic
cases, the shunt ratio determines the treatment. The risk of
encephalopathy increases with increasing shunt ratios. If
the shunt ratio exceeds 60%, treatment is needed, even
without hepatic encephalopathy (11). Our patient’s shunt
ratio was extremely high and his blood ammonia level was
four times the normal range; thus, we decided on a
therapeutic intervention.
Aside from dietary control, surgical operations such as
shunt ligation and hepatic resection were performed in the
past years (1, 4). Recently, however, less invasive percuta-
neous intervention has been widely adopted. Previous
reports describe several percutaneous techniques for
treating these shunts using various embolic agents and
variable approach routes (5, 6, 12). However, we believe
that our patient’s shunts were too large to embolize with
coils or other embolic agents, because of the potential
complications of migration. Occlusion of the shunt risks
causing portal hypertension (13). Our patient displayed
mild splenomegaly; however, the size of the spleen did not
differ significantly between the imaging studies performed
two and four weeks after embolization. Considering the
right portal vein’s growth, we don’t expect portal vein
hypertension to progress; however, the boy will need
additional close follow-up.
To our knowledge, no reported cases of congenital
IPSVS have been treated by AVP, which can be used to
occlude large, high-flow vessels. Recent reports do exist
about the use of this device, other than the first introduced
era (14, 15). Unlike embolization coils, an AVP can be
positioned accurately, and migration of the AVP is
uncommon. In the present case, we successfully occluded
the large shunt using AVPs with clinical success and
without AVP-related complications. 
The bleeding episode, following shunt embolization in
our patient, occurred through the sheath tract. A shunt
occlusion must lead to an increase in blood flow and
pressure in the right portal vein, and our method of tract
embolization was insufficient for hemostasis.
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embolic agents including coils, gelfoam, and glue have
been reported in cases of transhepatic portal vein approach
or biopsy (16-19). An appropriate method must be chosen
by considering the hemodynamic change after the
procedure. Moreover, the confirmation of hemostasis is
important. 
Like our case, nodular liver lesions associated with
congenital portosystemic shunts are not a rare condition (4,
20). Most of these lesions such as FNH or nodular regener-
ative hyperplasia, are benign (4). Regenerative liver lesions
have been attributed to the diminution of portal flow and
compensatory increase in hepatic arterial flow. The
increased levels of hepatic growth factors through systemic
circulation are also regarded as causative (4). Because the
regenerative nodules are well described in congenital
portosystemic shunts; and, because of the bleeding risk
associated with a biopsy due to the hypervascular nature
of CT scans, we decided to conduct a follow-up evaluation
of the patient’s mass lesion (21). Our patient’s mass had
been dramatically reduced after just a short follow-up
period, which led us to conclude that the mass was most
likely benign because of the increased portal flow to liver’s
right lobe, as described earlier (4).
In conclusion, IPSVS occlusion with an AVP is safe and
effective, and shunt occlusion is a beneficial treatment
method for regenerative liver lesions, as well as decreasing
the risk of hepatic encephalopathy. 
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